Welcome to our dedicated page for Cronos Group SEC filings (Ticker: CRON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cronos Group Inc. (CRON), a cannabinoid-focused company listed on NASDAQ and the Toronto Stock Exchange. As a foreign private issuer incorporated in British Columbia, Canada, Cronos files reports with the SEC under Commission File Number 001-38403, giving investors structured insight into its operations, governance and financial condition.
Cronos’ SEC disclosure includes current reports on Form 8-K, which the company uses to announce material events. Recent 8-K filings have covered quarterly financial results, such as press releases for the second and third quarters of 2025, and corporate governance matters, including the appointment and subsequent termination of the company’s principal accounting officer and the results of the 2025 Annual Meeting of Shareholders. These filings provide detail on topics like voting outcomes for director elections, advisory votes on executive compensation and the appointment of the independent auditor.
Through this filings page, users can also review Cronos’ periodic reports (such as annual and quarterly filings referenced in its 8-Ks) to understand trends in revenue, gross profit, adjusted EBITDA and other metrics the company discusses in its earnings materials. The filings describe elements of Cronos’ business, including its cannabis brands, international operations and investments such as its interest in Cronos Growing Company Inc. (Cronos GrowCo).
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important changes in financial performance, governance or strategy. Real-time updates from the EDGAR system ensure that new Cronos 8-Ks, 10-K equivalents for foreign issuers, 10-Q equivalents and proxy materials are added as they are filed, while insider transaction reports on Form 4, if applicable, can be used to monitor share dealings by directors and officers.
By combining Cronos’ official SEC filings with AI-generated explanations, this page is designed to make the company’s regulatory disclosures more accessible to investors, analysts and other stakeholders.
Cronos Group Inc. director and officer Michael Ryan Gorenstein exercised restricted stock units into common shares and had a portion withheld for taxes. He converted 339,879 RSUs into 339,879 common shares. Of these, 132,991 common shares were withheld at $2.56 per share to cover tax obligations, a non‑market disposition.
After these transactions, he directly holds 13,016,183 common shares and no remaining derivative position from this RSU grant. The RSUs exercised are part of a larger award of 1,019,736 RSUs that vest in three substantially equal annual installments beginning on the first anniversary of the March 12, 2025 grant date.
Cronos Group Inc. Chief Growth Officer Jeffrey David Jacobson exercised restricted stock units into common shares. He converted 65,179 RSUs, with each unit delivering one common share. A portion of the resulting 65,179 common shares was used to satisfy tax obligations, with 24,926 shares withheld at a price of $2.56 per share. After these compensation-related and tax-withholding transactions, Jacobson directly owned 448,042 common shares.
Cronos Group Inc. executive Anna Shlimak exercised 47,368 restricted stock units (RSUs) into an equal number of common shares. The RSUs had a conversion price of $0.00 per share, reflecting a routine vesting event rather than an open‑market purchase.
To cover tax obligations related to this vesting, 17,230 common shares were withheld at a reported price of $2.56 per share, which is not an open‑market sale. After these transactions, Shlimak directly holds 311,061 common shares and 460,548 RSUs. A prior grant of 142,105 RSUs vests in three substantially equal annual installments beginning on the first anniversary of its grant date.
Cronos Group Inc. officer Buggy Shannon exercised restricted stock units into common shares as part of equity compensation. On March 12, 2026, 21,930 RSUs converted into 21,930 common shares at a stated price of $0.00 per share.
To cover tax obligations from this vesting, 9,728 common shares were withheld at $2.56 per share and delivered back to the issuer. After these transactions, Shannon directly owned 155,143 common shares of Cronos Group Inc.
Cronos Group Inc. reported that company officer Terrence Gregory Joseph Doucet exercised restricted stock units into common shares. On March 12, 2026, he converted 23,809 RSUs into the same number of common shares at a stated price of $0.00 per share.
To cover tax obligations related to this vesting, 12,235 common shares were withheld at a price denominated in Canadian dollars of $3.48 per share, leaving a net increase of 11,574 common shares. Following these transactions, he directly owned 93,569 common shares and 208,305 restricted stock units, with the RSUs originally granted as 71,428 units on March 12, 2025 vesting in three equal annual installments.
Wagner Adam reported acquisition or exercise transactions in this Form 4 filing.
Cronos Group Inc. reported that officer Adam Wagner received a grant of restricted stock units as part of his equity compensation. On March 9, 2026, he was awarded 63,189 RSUs, each representing the right to receive one common share of Cronos Group Inc. The RSUs vest in three substantially equal annual installments beginning on the first anniversary of the grant date, meaning the award will deliver shares over a three-year period if vesting conditions are met. Following this grant, Wagner holds 201,821 restricted stock units directly, aligning his compensation more closely with the company’s share performance.
Cronos Group Inc. reported that officer Terrence Gregory Joseph Doucet received and exercised equity awards rather than trading shares on the open market. On March 9, 2026, he was granted 80,555 restricted stock units (RSUs), each representing a contingent right to receive one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 8, 2026, he exercised 24,434 RSUs into the same number of common shares, then had 12,580 common shares withheld at $3.51 per share to cover tax obligations, a non–open-market disposition. Following these transactions, he directly held 81,995 common shares and 232,114 RSUs, reflecting routine compensation and vesting activity rather than discretionary buying or selling.
Cronos Group Inc. reported that officer Arye Weigensberg received an equity compensation grant and exercised previously awarded units. On March 9, 2026, he was granted 63,919 restricted stock units (RSUs), each representing the right to receive one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 8, 2026, Weigensberg exercised 21,484 RSUs previously granted, acquiring the same number of common shares at a price of $0.00 per share. Following these transactions, he directly holds 157,376 common shares and 196,353 RSUs, reflecting routine compensation-related equity activity without any open-market purchases or sales.
Cronos Group Inc. reported equity compensation and related share movements for Chief Growth Officer Jeffrey David Jacobson. On March 9, 2026, he received a grant of 144,561 restricted stock units (RSUs), each representing a contingent right to one common share, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 8, 2026, he exercised 60,536 RSUs into the same number of common shares, and 25,605 common shares were withheld at $2.57 per share to satisfy tax obligations. Following these transactions, he directly holds 407,789 common shares and 459,845 RSUs.
Cronos Group Inc. director and officer Michael Ryan Gorenstein reported equity compensation and related share movements. On March 9, 2026, he received a grant of 904,669 restricted stock units (RSUs), each representing one common share, bringing his RSU holdings to 2,576,845.
On March 8, 2026, he exercised 327,801 RSUs into the same number of common shares. To cover tax obligations, 128,918 common shares were withheld at $2.57 per share. After these transactions, he directly holds 12,809,295 common shares, plus his RSU awards.